• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由USF1激活的hsa_circ_0076691通过以依赖miR-589-3p的方式促进FGF9表达来诱导奥沙利铂耐药。

USF1-activated hsa_circ_0076691 induces oxaliplatin resistance via facilitating FGF9 expression in miR-589-3p-dependent manners.

作者信息

Tang Lingyu, Deng Xuan, Guan Ming, Zhong Liang

机构信息

Department of Gastroenterology and Endoscopy, Huashan Hospital, Fudan University, Shanghai, 200040, China.

Department of Laboratory Medicine, Huashan Hospital Fudan University, Shanghai, 200040, China.

出版信息

Noncoding RNA Res. 2025 Apr 8;13:15-28. doi: 10.1016/j.ncrna.2025.04.003. eCollection 2025 Aug.

DOI:10.1016/j.ncrna.2025.04.003
PMID:40529209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12173138/
Abstract

Chemotherapeutic efficacy in colorectal cancer (CRC) is significantly hindered by the development of drug resistance. Emerging evidence indicates that circular RNAs (circRNAs) play pivotal roles in various cancer-related biological processes. Nonetheless, the specific role of circRNAs in oxaliplatin resistance in CRC remains largely unexplored. In this study, hsa_circ_0076691 (circ76691) overexpression was observed in the oxaliplatin-resistant CRC group and could predict poor prognosis. Functional analyses revealed that circ76691 attenuates oxaliplatin-induced apoptosis both and , thereby contributing to enhanced oxaliplatin resistance. Mechanistically, circ76691 transcriptionally downregulates miR-589-3p expression and acts as a molecular sponge for miR-589-3p, sequestering it from its downstream targets. Notably, fibroblast growth factor 9 (FGF9), identified as a downstream inhibitory target of miR-589-3p, is subsequently upregulated due to circ76691 activity. Furthermore, circ76691 expression is transcriptionally induced by USF1 through direct binding to its promoter region. Collectively, these findings elucidate the USF1/circ76691/miR-589-3p/FGF9 axis in inhibiting oxaliplatin-induced apoptosis, suggesting circ76691 as a potential therapeutic target to enhance the efficacy of platinum-based therapy.

摘要

结直肠癌(CRC)中的化疗疗效因耐药性的产生而受到显著阻碍。新出现的证据表明,环状RNA(circRNA)在各种癌症相关的生物学过程中发挥着关键作用。然而,circRNA在CRC对奥沙利铂耐药中的具体作用在很大程度上仍未得到探索。在本研究中,在奥沙利铂耐药的CRC组中观察到hsa_circ_0076691(circ76691)过表达,并且其可预测不良预后。功能分析显示,circ76691在体内和体外均减弱奥沙利铂诱导的细胞凋亡,从而导致奥沙利铂耐药性增强。机制上,circ76691转录下调miR-589-3p的表达,并作为miR-589-3p的分子海绵,将其与其下游靶标隔离。值得注意的是,成纤维细胞生长因子9(FGF9)被鉴定为miR-589-3p的下游抑制靶标,随后由于circ76691的作用而上调。此外,circ76691的表达由USF1通过直接结合其启动子区域进行转录诱导。总的来说,这些发现阐明了USF1/circ76691/miR-589-3p/FGF9轴在抑制奥沙利铂诱导的细胞凋亡中的作用,表明circ76691作为增强铂类疗法疗效的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/71f3467cba6c/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/104e9d7c766e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/cc481a749f3e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/65c9af22a138/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/1edff6e1be68/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/fb83b865932c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/60c2359a74d2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/f713c5e05d36/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/71f3467cba6c/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/104e9d7c766e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/cc481a749f3e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/65c9af22a138/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/1edff6e1be68/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/fb83b865932c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/60c2359a74d2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/f713c5e05d36/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702c/12173138/71f3467cba6c/gr8.jpg

相似文献

1
USF1-activated hsa_circ_0076691 induces oxaliplatin resistance via facilitating FGF9 expression in miR-589-3p-dependent manners.由USF1激活的hsa_circ_0076691通过以依赖miR-589-3p的方式促进FGF9表达来诱导奥沙利铂耐药。
Noncoding RNA Res. 2025 Apr 8;13:15-28. doi: 10.1016/j.ncrna.2025.04.003. eCollection 2025 Aug.
2
Circulating exosome-circRNAs mediated downregulation of FGF9 through ceRNA mechanism aggravates renal fibrosis in diabetic nephropathy.循环外泌体circRNA通过ceRNA机制介导的FGF9下调加重糖尿病肾病中的肾纤维化。
PLoS One. 2025 Jun 17;20(6):e0326217. doi: 10.1371/journal.pone.0326217. eCollection 2025.
3
circ-NOLC1 inhibits the development of cervical cancer by regulating miR-330-5p-PALM signaling axis.环状非编码RNA NOLC1通过调控miR-330-5p-PALM信号轴抑制宫颈癌的发展。
Hereditas. 2025 Jun 18;162(1):108. doi: 10.1186/s41065-025-00478-5.
4
LncRNA H19 acts as a ceRNA to promote glioblastoma malignancy by sponging miR-19b-3p and upregulating SERPINE1.长链非编码RNA H19作为一种竞争性内源RNA,通过吸附miR-19b-3p并上调丝氨酸蛋白酶抑制剂E1(SERPINE1)来促进胶质母细胞瘤的恶性进展。
Cancer Cell Int. 2025 Jun 19;25(1):217. doi: 10.1186/s12935-025-03868-x.
5
Circular RNA hsa_circ_0005218 promotes the early recurrence of hepatocellular carcinoma by targeting the miR-31-5p/CDK1 pathway.环状RNA hsa_circ_0005218通过靶向miR-31-5p/CDK1途径促进肝细胞癌的早期复发。
Heliyon. 2023 Mar 22;9(4):e14816. doi: 10.1016/j.heliyon.2023.e14816. eCollection 2023 Apr.
6
A novel circular RNA circ_0020647 promotes ETEC-induced IPEC-J2 cell pyroptosis via the ssc-miR-185/BRD4 axis.一种新型环状RNA circ_0020647通过ssc-miR-185/BRD4轴促进肠毒素大肠杆菌诱导的IPEC-J2细胞焦亡。
Front Vet Sci. 2025 Jun 4;12:1578941. doi: 10.3389/fvets.2025.1578941. eCollection 2025.
7
circRNA hsa_circ_0072107 aggravates myocardial hypertrophy via its function as a competitive endogenous RNA of miR‑516b‑5p.环状RNA hsa_circ_0072107通过作为miR-516b-5p的竞争性内源性RNA发挥作用,加重心肌肥大。
Mol Med Rep. 2025 Sep;32(3). doi: 10.3892/mmr.2025.13597. Epub 2025 Jun 20.
8
Targeting Drp1 inhibits ESCC progression via the ROS-PGC1-α-Nrf1/2 pathway.靶向动力相关蛋白1(Drp1)通过活性氧(ROS)-过氧化物酶体增殖物激活受体γ共激活因子1α(PGC1-α)-核因子E2相关因子1/2(Nrf1/2)途径抑制食管鳞状细胞癌(ESCC)进展。
J Transl Med. 2025 Jun 17;23(1):674. doi: 10.1186/s12967-025-06697-8.
9
Hsa_circ_0125356 promotes gemcitabine resistance by modulating WNT canonical and non-canonical pathways via miR-582-5p/FGF9 axis in non-small cell lung cancer.Hsa_circ_0125356通过miR-582-5p/FGF9轴调控非小细胞肺癌中的WNT经典和非经典途径来促进吉西他滨耐药。
Mol Cancer. 2025 Feb 27;24(1):59. doi: 10.1186/s12943-025-02259-0.
10
tsRNA-08614 inhibits glycolysis and histone lactylation by ALDH1A3 to confer oxaliplatin sensitivity in colorectal cancer.tsRNA-08614通过醛脱氢酶1A3(ALDH1A3)抑制糖酵解和组蛋白乳酸化,从而赋予结直肠癌对奥沙利铂的敏感性。
Transl Oncol. 2025 Aug;58:102427. doi: 10.1016/j.tranon.2025.102427. Epub 2025 Jun 5.

引用本文的文献

1
A review of circular RNAs in colorectal cancer: insights into biomarker discovery and therapeutic targeting.结直肠癌中环状RNA的综述:对生物标志物发现和治疗靶点的见解
Front Oncol. 2025 Jul 4;15:1549046. doi: 10.3389/fonc.2025.1549046. eCollection 2025.

本文引用的文献

1
CircPDIA3/miR-449a/XBP1 feedback loop curbs pyroptosis by inhibiting palmitoylation of the GSDME-C domain to induce chemoresistance of colorectal cancer.CircPDIA3/miR-449a/XBP1 反馈环路通过抑制 GSDME-C 结构域的棕榈酰化来抑制细胞焦亡,从而诱导结直肠癌细胞的化疗耐药性。
Drug Resist Updat. 2024 Sep;76:101097. doi: 10.1016/j.drup.2024.101097. Epub 2024 May 28.
2
JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles.JASPAR 2024:转录因子结合谱开放获取数据库的 20 周年纪念
Nucleic Acids Res. 2024 Jan 5;52(D1):D174-D182. doi: 10.1093/nar/gkad1059.
3
Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy.
新兴的铂(IV)前药纳米疗法:铂基癌症治疗的新纪元。
J Control Release. 2023 Sep;361:819-846. doi: 10.1016/j.jconrel.2023.08.035. Epub 2023 Aug 23.
4
Going circular: history, present, and future of circRNAs in cancer.环状 RNA 与癌症:历史、现状与未来。
Oncogene. 2023 Sep;42(38):2783-2800. doi: 10.1038/s41388-023-02780-w. Epub 2023 Aug 16.
5
Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer.抑制 CDK1 通过调节 ACSL4 介导的结直肠癌细胞铁死亡克服奥沙利铂耐药性。
Adv Sci (Weinh). 2023 Sep;10(25):e2301088. doi: 10.1002/advs.202301088. Epub 2023 Jul 10.
6
RUNX2 and Cancer.RUNX2 与癌症。
Int J Mol Sci. 2023 Apr 10;24(8):7001. doi: 10.3390/ijms24087001.
7
Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy.肠道微生物群对癌症化疗和免疫治疗疗效及毒性的调节作用
Gastroenterology. 2023 Feb;164(2):198-213. doi: 10.1053/j.gastro.2022.10.018. Epub 2022 Oct 27.
8
Upregulation of Superenhancer-Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma.USF1 上调超级增强子驱动的长链非编码 RNA FASRL 促进从头脂肪酸生物合成,加剧肝细胞癌
Adv Sci (Weinh). 2022 Oct 28;10(1):e2204711. doi: 10.1002/advs.202204711.
9
Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance.药物代谢、致癌信号调节和肿瘤微环境在微生物介导的胰腺癌化疗耐药中的作用。
Drug Resist Updat. 2022 Sep;64:100864. doi: 10.1016/j.drup.2022.100864. Epub 2022 Sep 6.
10
CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.环状 RNA-CREIT 通过使 PKR 不稳定来抑制应激颗粒组装并克服 TNBC 对多柔比星的耐药性。
J Hematol Oncol. 2022 Aug 29;15(1):122. doi: 10.1186/s13045-022-01345-w.